wegovy novo nordisk - Search News

Novo Suffers Wegovy Trial Setback

Hosted on MSN · 1d

Novo Suffers Wegovy Trial Setback as US Plans to Cut Price

Novo Nordisk A/S’s blockbuster drug Wegovy was targeted for price cuts by the US government and suffered a setback in a new trial, adding to growing threats to the Danish company’s early dominance in the surging market for new weight-loss treatments.

MarketWatch on MSN · 1d

Tripling Wegovy dosage leads to more weight loss, Novo Nordisk trial shows

Tripling the dosage of the Wegovy weight-loss drug leads to more weight loss, Novo Nordisk said Friday. The Danish drugmaker announced results from a Phase 3B trial of semaglutide at a 7.2 milligram dosage,

High-dose Wegovy leads to substantial weight loss in trial, but falls short of Zepbound

A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less than what’s been seen with Zepbound.

Ozempic, Wegovy face US Medicare price negotiations

Novo's Ozempic, Wegovy picked for US Medicare price negotiations

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for Medicare price negotiations for 2027, the U.S. government said on Friday, part of a law pharmaceutical companies have pledged to revisit with the Trump administration.

The Washington Post on MSN · 21h

Medicare to negotiate price of Ozempic, Wegovy weight-loss drugs

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Medicare drug price negotiations to target Ozempic, Wegovy and other drugs

The hugely popular medications Ozempic and Wegovy, used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.

1don MSN

Novo Nordisk’s Wegovy Achieves Weight-Loss of 20.7% at Higher Dose, Study Says

Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, ...

7h

Is Novo Nordisk Stock a Buy?

Novo is currently in a golden age of growth. Over the last five years, its trailing-12-month revenue grew by 109%, reaching ...

1d

Ozempic, Wegovy among drugs selected for Medicare's price negotiations

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

1d

Wegovy at Higher Dose Achieves Greater Weight Loss in Trial

Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, ...

1don MSN

These Stocks Are Moving the Most Today: Apple, Qorvo, Novo Nordisk, SLB, J.B. Hunt, Rivian, Cloudflare, and More

Stocks rallied sharply Friday and the S&P 500 was on pace for its best week since early November.These stocks were making ...

3d

Novo Nordisk: Excellent Opportunity To Buy The Dip

Novo Nordisk's financial strength is evident through its 74% historical average ROIC and 85% gross margin. See why I rate NVO ...

Novo Nordisk's valuation now more attractive: Bernstein

Investing.com -- Bernstein analysts highlighted a more attractive valuation for Novo Nordisk (NYSE: NVO) following recent ...

4d

Wider benefits of Ozempic, Wegovy put pressure on Canadian insurers to expand drug coverage

Canadian public and private insurers have balked at covering certain medication for weight-loss, but that might change as the ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results